Camptothecins in Cancer Therapy

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critic...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Adams, Val R. (Editor), Burke, Thomas G. (Editor)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press, 2005.
Series:Cancer Drug Discovery and Development
Subjects:
Online Access:Full Text via HEAL-Link

Similar Items